Oncotarget

Vol 10, No 48

August 13, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 48 of Oncotarget features Figure 2, "Analysis of p-Akt and PRR expression in prostate cancer tissue microarrays," by Mohammad, et al.

Table of Contents

News

CD9: A possible clue into breast cancer chemoresistance

CD9: A possible clue into breast cancer chemoresistance

https://doi.org/10.18632/oncotarget.27130

Natalia Pacienza,  and Gustavo Yannarelli
4921-4922
PDF  |  How to cite  |  Order a Reprint

Research Papers

V-ATPase-associated prorenin receptor is upregulated in prostate cancer after PTEN loss

V-ATPase-associated prorenin receptor is upregulated in prostate cancer after PTEN loss

https://doi.org/10.18632/oncotarget.27075

Amro H. Mohammad, Sarah Assadian, Frédéric Couture, Karen J. Lefebvre, Wissal El-Assaad, Veronique Barrès, Veronique Ouellet, Pierre-Luc Boulay, Jieyi Yang, Mathieu Latour, Luc Furic, William Muller, Nahum Sonenberg, Anne-Marie Mes-Masson, Fred Saad, Robert Day,  and Jose G. Teodoro
4923-4936
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

ALK mutation dynamics and clonal evolution in a neuroblastoma model exhibiting two ALK mutations

ALK mutation dynamics and clonal evolution in a neuroblastoma model exhibiting two ALK mutations

https://doi.org/10.18632/oncotarget.27119

Simon Durand, Cécile Pierre-Eugène, Olivier Mirabeau, Caroline Louis-Brennetot, Valérie Combaret, Léo Colmet-Daage, Orphée Blanchard, Angela Bellini, Estelle Daudigeos-Dubus, Virginie Raynal, Gudrun Schleiermacher, Sylvain Baulande, Olivier Delattre,  and Isabelle Janoueix-Lerosey
4937-4950
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

PTEN interacts with RNA polymerase II to dephosphorylate polymerase II C-terminal domain

PTEN interacts with RNA polymerase II to dephosphorylate polymerase II C-terminal domain

https://doi.org/10.18632/oncotarget.27128

Ata Abbas, Todd Romigh,  and Charis Eng
4951-4959
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins

Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins

https://doi.org/10.18632/oncotarget.27131

Manabu Sasada, Takuya Iyoda, Tatsufumi Asayama, Yusuke Suenaga, Shunsuke Sakai, Naoya Kase, Hiroaki Kodama, Sana Yokoi, Yoichiro Isohama,  and Fumio Fukai
4960-4972
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy

Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy

https://doi.org/10.18632/oncotarget.27132

Cornelia Schroeder, Elham Navid-Hill, Jan Meiners, Claudia Hube-Magg, Martina Kluth, Georgia Makrypidi-Fraune, Ronald Simon, Franziska Büscheck, Andreas M. Luebke, Cosima Goebel, Dagmar S. Lang, Sören Weidemann, Emily Neubauer, Andrea Hinsch, Frank Jacobsen, Patrick Lebok, Uwe Michl, Dirk Pehrke, Hartwig Huland, Markus Graefen, Thorsten Schlomm, Guido Sauter,  and Doris Höflmayer
4973-4986
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Methylation alteration of SHANK1 as a predictive, diagnostic and prognostic biomarker for chronic lymphocytic leukemia

Methylation alteration of SHANK1 as a predictive, diagnostic and prognostic biomarker for chronic lymphocytic leukemia

https://doi.org/10.18632/oncotarget.27080

Eleonora Loi, Loredana Moi, Antonio Fadda, Giannina Satta, Mariagrazia Zucca, Sonia Sanna, Shadi Amini Nia, Giuseppina Cabras, Marina Padoan, Corrado Magnani, Lucia Miligi, Sara Piro, Davide Gentilini, Maria Grazia Ennas, Melissa C. Southey, Graham G. Giles, Nicole Wong Doo, Pierluigi Cocco,  and Patrizia Zavattari
4987-5002
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Corrections

Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy

Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy

https://doi.org/10.18632/oncotarget.27151

Annalisa Petrelli, Rosachiara Carollo, Marilisa Cargnelutti, Flora Iovino, Maurizio Callari, Daniela Cimino, Matilde Todaro, Laura Rosa Mangiapane, Alessandro Giammona, Adriana Cordova, Filippo Montemurro, Daniela Taverna, Maria Grazia Daidone, Giorgio Stassi,  and Silvia Giordano
5003-5004
Correction  |  PDF  |  How to cite


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC